PSUs to seek approval from Niti Aayog for joint ventures -Governance Now

PSUs to seek approval from Niti Aayog for joint ventures

It is to ensure that the deployment of public funds in such joint ventures and subsidiaries is made after due scrutiny and adequate justification

GN Bureau | October 15, 2016

#Niti Aayog #PSUs #joint ventures #Arun Jaitley #department of public enterprises

The NITI Aayog, besides identifying PSUs for strategic sales and monitoring the closure of loss making firms, will now also give approvals to the state-run entities to set up financial joint ventures, a power which rested with company boards.

According to a news report published in the Business Line, the department of public enterprises (DPE), which essentially monitors the functioning of state-owned entities, has recently come out with guidelines asking the PSUs to seek ‘concurrence’ from NITI Aayog for such joint ventures.

It said that the aim to ensure that the deployment of public funds in such joint ventures and subsidiaries is made after “due scrutiny and adequate justification”.

Earlier, the boards took a call on technology joint ventures and strategic alliance. Only in certain cases nod from the administrative ministry was sought.

The DPE has said that once such proposals are cleared by the boards, administrative ministries must also seek the approval of the NITI Aayog, to check the “proliferation of financial joint ventures and wholly owned subsidiaries” by Maharatna, Navratna and Miniratna PSUs. Although DPE continues to be the nodal authority for all PSUs, in some instances like this, the NITI Aayog has been brought in as an additional layer of oversight, the report added.

Earlier, in the budget 2016-17, finance minister Arun Jaitley had entrusted the responsibility to identify PSUs for strategic sale to the NITI Aayog, which has already submitted a two-part report on the issue and is working on the other report.

The NITI Aayog is a think tank to the government for providing policy inputs as well as designing strategic and long-term programmes for the centre and the states.

Comments

Other News

Retail inflation crosses 6% mark

Retail inflation based on Consumer Price Index for October has reached 6.09%, whereas year-on-year food inflation, based on Consumer Food Price Index, for October is 8.94%, an official release said on Thursday. Year-on-year inflation rate based on All India Consumer Price I

Cabinet approves museum at North-South Block complex

The Cabinet Committee on Economic Affairs, chaired by prime minister Narendra Modi, on Wednesday has approved the development of the Yuge Yugeen Bharat Museum (YYBM) at the North and South Block Complex, New Delhi, at an estimated total project cost of ₹3,230 crore, as appraised by the Public Investmen

Cabinet approves extension of Noida metro corridor

The Union Cabinet, chaired by prime minister Narendra Modi, has approved the extension of Aqua Line Metro Rail Corridor from Noida Sector-51 to Greater Noida Sector-04 of Noida Metro Rail Project with corridor for a length of 8.449 km with 5 elevated stations. On operationalization of this corridor, Noid

India reaffirms commitment to climate multilateralism

India has reaffirmed its commitment to climate multilateralism and the principles of Equity and Common But Differentiated Responsibilities and Respective Capabilities (CBDR-RC), calling for a fair, equitable and ambitious outcome at the 31st Conference of the Parties (COP31) to the United Nations Framewo

How the mind can help the body heal itself

Why do some people recover from illness against all odds? Can our beliefs, emotions and consciousness influence the body’s ability to heal? Drawing on over three decades of experience in medicine, research and medical innovation, internationally trained ophthalmologist and author Dr Dinesh Verma ex

1,364 anti-cancer formulations to cost less from today

The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, has capped trade margins on the Maximum Retail Price (MRP) of 137 anti-cancer drugs. This was based on the recommendations of an Expert Committee constitute